Arabic Arabic English English French French German German
dark

Successful demonstration of BioDrone® platform-based drug delivery and confirmed restoration of the myogenic potential of Prokr1-deficient C2C12 myoblasts

MDimune Inc., a leading cell-derived vesicles (CDVs) company in South Korea has announced the outcomes of the research collaboration with Prof. Joonghoon Park’s team at Seoul National University. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Alzheon to Present at H.C. Wainwright Annual Global Investment Conference on September 13, 2021

Next Post

ADC Therapeutics Receives Orphan Drug Designation in Europe for ZYNLONTA®

Related Posts
Total
0
Share